CMV

COMMUNIQUÉS West-GlobeNewswire

Vor Bio Announces Oral Presentation of 48-Week China Phase 3 Generalized Myasthenia Gravis Clinical Study at AANEM
17/09/2025
CAMBRIDGE, Mass., Sept. 17, 2025 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced that 48-week clinical data from the [...]
CooperCompanies Announces Expanded Share Repurchase Program
17/09/2025
SAN RAMON, Calif., Sept. 17, 2025 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, announced today its Board of Directors has approved a $1 billion increase in the Company’s [...]
Biogen Receives European Commission Approval for ZURZUVAE® (zuranolone), the First and Only Treatment Approved for Women with Postpartum Depression in Europe
17/09/2025
Postpartum depression is a leading cause of maternal mortality in Europe 1-2 , and is one of the most common medical conditions associated with pregnancy 3-5 ; up to 20% of women experience postpartum depressive [...]
Arvinas Provides Update on Collaboration with Pfizer and Announces Further Actions to Support Value Creation
17/09/2025
Arvinas and Pfizer plan to jointly select third party for the out-licensing and commercialization of vepdegestrant Additional cost optimization measures expected to realize total annual savings of more than $100 million [...]
Eagle Pharmaceuticals Announces Availability of Proxy Materials and Audited Financial Statements for the 2023 and 2024 Fiscal Years
17/09/2025
WOODCLIFF LAKE, N.J., Sept. 17, 2025 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (OTCMKTS: EGRX) (the “Company” or “Eagle”) today announced the availability of proxy materials for its 2025 Annual Meeting of [...]
Bionano Genomics, Inc. Announces Closing of $10 Million Public Oﬀering
17/09/2025
SAN DIEGO, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ: BNGO) (“Bionano” or the “Company”) today announced the closing of its previously announced public offering of an aggregate of 5,000,000 [...]
Novo Nordisk’s oral semaglutide 25 mg (Wegovy® in a pill*) delivered 16.6% weight loss in people with obesity in a newly published study
17/09/2025
Oral semaglutide 25 mg (the once-daily pill formulation of Wegovy ® ) achieved significant weight loss, with one in three study participants losing 20% or more body weight 1 ** Oral semaglutide 25 mg also demonstrated [...]
Esteworld Concludes Four-Day Consultation Series at Covent Garden, London
17/09/2025
Photo: Esteworld Representative Office - Covent Garden, London LONDON, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Esteworld Health Group has concluded a four-day series of face-to-face consultation sessions at its Covent Garden [...]
Thirty Inspiring Middle School Scientists and Engineers Shine as Finalists in the Thermo Fisher Scientific Junior Innovators Challenge
17/09/2025
Representing 10 U.S. states and Puerto Rico, finalists will compete in Washington, D.C., for more than $100,000 in awards WASHINGTON, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Society for Science today announced the 30 [...]
Amid 7-OH Health Warnings, Happy Go Leafy Introduces Pure Kratom Line for Safer Wellness
17/09/2025
Happy Go Leafy responds to 7-OH concerns with a new pure kratom line. Lab-tested and transparent products designed to support safer wellness use. Miami, Florida, Sept. 17, 2025 (GLOBE NEWSWIRE) -- 2025 has seen urgent [...]
The Association of American Physicians and Surgeons (AAPS) Supports HHS Secretary Kennedy and Making America Healthy Again (MAHA)
17/09/2025
TUCSON, Ariz., Sept. 17, 2025 (GLOBE NEWSWIRE) -- On September 13, at its 82 nd annual meeting in Chantilly, VA, the Association of American Physicians and Surgeons (AAPS) passed the following emergency resolution, [...]
Candel Therapeutics to Present Phase 3 Results of CAN-2409 in Localized Prostate Cancer at ASTRO 2025
17/09/2025
NEEDHAM, Mass., Sept. 17, 2025 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal biological immunotherapies [...]
iPETcertum™ by Claritas, State-of-the-Art Software for Enhancement, Automated Segmentation and Accurate Quantification in PET, PET-CT/MRI Scans, Receives Clearance from Brazilian Regulator ANVISA
17/09/2025
NEW YORK and LONDON and SAO PAULO, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Claritas NucMed Tech Brazil S.A. (“Claritas NucMed Brazil”), a subsidiary of UK-based Claritas NucMed Technologies Ltd (“Claritas NucMed”), a company [...]
Intelligent Bio Solutions Provides Update on FDA 510(k) Clearance Process for Intelligent Fingerprinting Drug Screening System
17/09/2025
NEW YORK, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today [...]
CDT Executes Cryptocurrency Treasury Reserve Strategy
17/09/2025
Initial digital asset acquisition marks milestone in capital diversification initiative NAPLES, Fla. And CAMBRIDGE, United Kingdom, Sept. 17, 2025 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT ) (“CDT” or the “ [...]
Vivos Therapeutics Announces Landmark Clinical Trial Results in Pediatric Obstructive Sleep Apnea Treatment
17/09/2025
The European Journal of Pediatrics publishes the first-ever multicenter clinical trial results demonstrating that the Vivos DNA appliance — part of the company’s C.A.R.E. line of devices— is both safe and effective for [...]
Safety Shot Announces Strategic Board Refresh to Align with New Corporate Vision
17/09/2025
Company Appoints New Directors with Deep Expertise in Venture Capital, Financial Due Diligence, and Bitcoin Mining to Guide Next Phase of Growth SCOTTSDALE, AZ, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Safety Shot, Inc. ( [...]
Vivani Medical Announces Record Date for Spin-off of Cortigent Neuromodulation Subsidiary to Shareholders
17/09/2025
Cortigent is a leading developer of brain implant devices based on precision neurostimulation technology. It is the only company to have obtained FDA approval of a device providing artificial vision for the profoundly [...]
Ernexa Therapeutics to Present New Data in Oral Presentation at AACR Special Conference in Cancer Research
17/09/2025
Presentation to highlight preclinical data from the company’s lead cell therapy, ERNA-101, demonstrating potential to reprogram the ovarian tumor microenvironment and advance toward clinical trials CAMBRIDGE, Mass., [...]

Pages